Rel-1,1'-((1R,3S,4S,6R)-4,6-bis(4-guanidinophenoxy)cyclohexane-1,3-diyl)diguanidine tetrakis(2,2,2-trifluoroacetate)

Catalog No. :
ACHPFB135
CAS No. :
2320930-10-5
Molecular Formula :
C22H32N12O2
Molecular Weight :
952.67

IUPAC Name:2,2'-((1R,3S,4S,6R)-4,6-bis(4-((diaminomethylene)amino)phenoxy)cyclohexane-1,3-diyl)diguanidine tetrakis(2,2,2-trifluoroacetate)

Rel-1,1'-((1R,3S,4S,6R)-4,6-bis(4-guanidinophenoxy)cyclohexane-1,3-diyl)diguanidine tetrakis(2,2,2-trifluoroacetate) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-1,1'-((1R,3S,4S,6R)-4,6-bis(4-guanidinophenoxy)cyclohexane-1,3-diyl)diguanidine tetrakis(2,2,2-trifluoroacetate)
IUPAC Name2,2'-((1R,3S,4S,6R)-4,6-bis(4-((diaminomethylene)amino)phenoxy)cyclohexane-1,3-diyl)diguanidine tetrakis(2,2,2-trifluoroacetate)
Molecular FormulaC22H32N12O2
Molecular Weight952.67
SMILESO([C@@H]1[C@@H](NC(=N)N)C[C@@H](NC(=N)N)[C@H](OC2=CC=C(NC(=N)N)C=C2)C1)C3=CC=C(NC(=N)N)C=C3
InChI KeyJYRRXGHBFAELIV-YAOLEPIASA-N
Synonymrel-N,N''-[[(1R,3S,4S,6R)-4,6-Bis[(aminoiminomethyl)amino]-1,3-cyclohexanedyil]bis(oxy-4,1-phenylene)]bisguanidine tetratrifluoroacetate salt
CAS No.2320930-10-5
PubChem CID121513857

Synthetic Route by SureRoute

1. ACHPFB135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHPFB135 route product structure diagram
    ACHPFB1352320930-10-5
Inquiry

2. ACHPFB135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHPFB135 route product structure diagram
    ACHPFB1352320930-10-5
Inquiry

Comments (0)